Why Omeros Stock Rose Last Week
On April 2, 2018, Omeros (OMER) stock opened at $11.12. It grew ~22% over the week to close at $13.58 on April 6.
What’s behind Omeros’s Cash Flow
In fiscal 2017, Omeros spent $36.2 million on operating activities, compared with $51.5 million in fiscal 2016.
A Look at Omeros’s Promising Research Pipeline
Omeros’s (OMER) research pipeline includes OMS721, which is undergoing Phase 3 trials.
Analysts’ Ratings for Omeros and Peers in March 2018
Omeros (OMER) is a commercial biopharmaceutical company. Its product, Omidria, is used in cataract surgery.